Editorial Comment to Activity of axitinib in patients with metastatic renal cell carcinoma previously treated with both vascular endothelial growth factor receptor tyrosine-kinase inhibitor and mammalian target of rapamycin inhibitor

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of urology 2014-07, Vol.21 (7), p.741-741
1. Verfasser:	Wada, Yoshihiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma, Renal Cell - drug therapy Female Humans Imidazoles - therapeutic use Indazoles - therapeutic use Kidney Neoplasms - drug therapy Male TOR Serine-Threonine Kinases - antagonists & inhibitors Vascular Endothelial Growth Factor Receptor-1 - antagonists & inhibitors Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!